Balchem Corporation · NASDAQ (us_market)
Basic Materials · Specialty Chemicals · United States
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
| Event Period | Drawdown | Buy Point (Bottom) | Sell Point (Peak) | ticker.setupCols.buyScore | ticker.setupCols.sellScore | Max Return | Algo Return |
|---|---|---|---|---|---|---|---|
DROP2023-08-30$142.72 RISE2023-10-27$115.08 PEAK2023-12-28$150.35 120d | -19.4% 58d | Missed | Missed | — | — | +30.6% 62d | Missed |
DROP2022-11-15$142.73 RISE2023-01-05$117.39 PEAK2023-02-07$142.06 84d | -17.8% 51d | Missed | Missed | — | — | +21.0% 33d | Missed |
DROP2022-08-25$141.48 RISE2022-09-27$119.70 PEAK2022-11-15$142.73 82d | -15.4% 33d | Missed | Missed | — | — | +19.2% 49d | Missed |
DROP2022-02-25$141.04 RISE2022-06-16$113.60 PEAK2022-08-25$141.48 181d | -19.5% 111d | Missed | Missed | — | — | +24.5% 70d | Missed |
DROP2021-12-31$168.60 RISE2022-05-11$116.17 PEAK2022-07-29$135.76 210d | -31.1% 131d | Missed | Missed | — | — | +16.9% 79d | Missed |
DROP2021-01-12$131.53 RISE2021-01-29$107.03 PEAK2021-03-10$131.25 57d | -18.6% 17d | Missed | Missed | — | — | +22.6% 40d | Missed |
DROP2020-02-20$112.07 RISE2020-06-26$87.34 PEAK2020-08-07$103.46 169d | -22.1% 127d | Missed | Missed | — | — | +18.5% 42d | Missed |
DROP2020-02-05$113.60 RISE2020-05-14$80.30 PEAK2020-08-07$103.46 184d | -29.3% 99d | Missed | Missed | — | — | +28.8% 85d | Missed |
DROP2020-02-05$113.60 RISE2020-03-12$81.49 PEAK2020-06-08$102.54 124d | -28.3% 36d | Missed | Missed | — | — | +25.8% 88d | Missed |
Investors need to pay close attention to BCPC stock based on the movements in the options market lately.
I present my top dividend growth picks for each of the 11 GICS sectors, emphasizing discounted valuations and safe, growing dividends.
In the first quarter of 2026, Balchem Corporation reported higher sales of US$270.71 million and net income of US$40.29 million year over year, while also completing a share repurchase of 159,539 shares for US$25.85 million under its December 2025 buyback program. The combination of earnings growth and disciplined capital returns via the buyback underscores how Balchem is using improving profitability to support shareholder-focused capital allocation. Next, we’ll examine how Balchem’s...
Trex Company is a leading provider of composite decking and outdoor living products for residential and commercial markets.
Clinical research shows MSM knee health featuring OptiMSM® supports knee quality of life, improves perceived knee comfort, and enhances overall health perceptions in adults with mild knee...
Conestoga Capital Advisors, an asset management company, released its first-quarter 2026 investor letter. A copy of the letter is available to download here. The first quarter of 2026 started with optimism about the domestic economy and attractive small-cap valuations, but it was affected by volatility due to geopolitical unrest in the Middle East and shifting expectations […]
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Balchem (NASDAQ:BCPC) with a Buy and raises the price target from $5.1 to $5.16.
FOR IMMEDIATE RELEASE Balchem Corporation Announces Global Price Increase for Animal Nutrition & Health Products Montvale, New Jersey, May 1, 202C. Balchem...
Moby summary of Balchem Corporation's Q1 2026 earnings call
The first quarter of 2026 was the twenty-seventh consecutive quarter of quarterly year-over-year growth in adjusted EBITDA for Balchem Corporation. Before we get into more detail on the quarter, I would like to make a few comments about the overall market environment, including the evolving geopolitical and macroeconomic situation, as well as some of the progress we have made on several important strategic initiatives.
Balchem Corporation (BCPC) Q1 2026 Earnings Call April 30, 2026 11:00 AM EDTCompany ParticipantsCarl Bengtsson - Executive VP, CFO, Treasurer and GM of...
Presentation Operator MessageOperator Thank you for standing by, and welcome to the Balchem's First Quarter 2026 Earnings Conference Call. [Operator Instructions] I'd now like to turn the call
Balchem reports record Q1 revenue of $270.7M and adjusted EPS of $1.33, beating estimates amid trade uncertainty.
2026-04-30. The following slide deck was published by Balchem Corporation in conjunction with their 2026 Q1 earnings call.
Balchem Corporation reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported sales was USD 270.71 million compared to USD 250.52 million a year...
Ted Harris, Chairman, President and CEO of Balchem said, The first quarter was an excellent start to the year for Balchem, with sales and earnings growth in all three segments. We delivered record...
Balchem (NASDAQ:BCPC) reported quarterly earnings of $1.33 per share which met the analyst consensus estimate. This is a 9.02 percent increase over earnings of $1.22 per share from the same period last year. The company
MONTVALE, N.J., April 30, 2026 -- Balchem Corporation reported today financial results for its 2026 fiscal first quarter ended March 31, 2026. For the quarter, the Company reported net sales of...
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| BCPC | -2.97% | -14.48% | +2.20% | -5.98% |
| XLB | -0.39% | -3.94% | +12.79% | +18.49% |
| Alpha (stock − sector) | -2.58% | -10.53% | -10.59% | -24.47% |
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| StateStreet | passive | 1.24M | $210.28M | 0.01% | Added+2.5% | 2026-03-31 |
| FidelityFMR | fundamental | 598.7K | $101.46M | 0.01% | Added+11.8% | 2026-03-31 |
| TwoSigma | quant | 430.2K | $72.91M | 0.06% | Added+112.2% | 2026-03-31 |
| RenTech | quant | 177.0K | $30.00M | 0.05% | Added+16.4% | 2026-03-31 |
| Citadel | multi-strat | 92.6K | $15.70M | 0.02% | Added+43.6% | 2026-03-31 |
| DEShaw | quant | 40.3K | $6.82M | 0.00% | Trimmed-43.4% | 2026-03-31 |
| Bridgewater | macro | 17.3K | $2.93M | 0.01% | Added+260.2% | 2026-03-31 |
| TRowePrice | fundamental | 208.4K | $35.32K | 0.00% | Added+20.2% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-07-30upcoming | 1.43 | — | — |
| 2026-04-30 | 1.33 | 1.33 | — |
| 2026-02-20 | 1.18 | 1.21 | +2.98% |
| 2025-10-21 | 1.31 | 1.35 | +3.05% |
| 2025-07-31 | 1.25 | 1.27 | +1.60% |
| 2025-04-24 | 1.22 | 1.22 | +0.41% |
| 2025-02-21 | 1.11 | 1.13 | +2.26% |
| 2024-10-25 | 1.12 | 1.13 | +1.35% |
| 2024-07-26 | 1.03 | 1.09 | +5.31% |
| 2024-05-03 | 0.98 | 1.03 | +5.10% |
| 2024-02-16 | 0.93 | 0.95 | +2.15% |
| 2023-10-27 | 0.97 | 1.04 | +7.22% |
| 2023-07-28 | 0.93 | 1.06 | +13.98% |
| 2023-04-28 | 0.82 | 0.94 | +14.63% |
| 2023-02-24 | 0.91 | 0.94 | +3.30% |
| 2022-11-04 | 1.03 | 1.00 | -2.91% |